Search results for "cancer diagnosis"
Selected Filters:
RealStar® SARS-CoV-2 RT-PCR Kit
altona DiagnosticsThe RealStar SARS-CoV-2 RT-PCR Kit 1.0 is a reagent system, based on real-time PCR technology, for the qualitative detection of lineage B-betacoronavirus (B-βCoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific RNA. SARS-CoV-2, formerly known as 2019-nCoV, is the causative agent of the coronavirus disease 2019 (COVID-19).
MagNA Pure 96 Instrument
RocheHigh-throughput robotic workstation for fully automated purification of nucleic acids from up to 96 samples.
New CRISPR-based test detects COVID-19 variants in your spit
Low-cost device lets consumers check themselves for multiple strains of SARS-CoV-2 at home
The Polyarc® System
Activated Research CompanyThe Polyarc system is a breakthrough innovation that combines catalysis with chemical analysis to revolutionize 60 year-old GC/FID technology. Give your FID a universal and uniform carbon response with a 7-order of magnitude linear range from
COVID-19 testing using lateral flow assays: sensitive, rapid, easy to use and point-of-care
Learn about the potential of lateral flow assays in detecting symptomatic and asymptomatic COVID-19 infections
QuantuMDx launches new PCR respiratory panel
New multiplex panel can detect SARS-CoV-2, Flu A, Flu B & RSV at the Point of Need
Curetis Group subsidiary Ares Genetics signs R&D and option agreement with leading global IVD corporation
R&D collaboration to develop NGS-based predictive antibiotic resistance testing powered by ARESdb
Waters at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo
Prepare your laboratory for the future with a global leader in mass spec Dx
FDA provides emergency use authorization to PerkinElmer for COVID-19 testing
Clinical laboratories can immediately begin using this kit to detect SARS-CoV-2
The Native Antigen Company introduces custom service for influenza antigens
Bespoke custom contract service offers rapid access to broad range of high-quality antigen panels for influenza A and B viruses
QIAseq Targeted DNA Pro Panels
QIAGENFor ease-of-use and biological insights using targeted DNA sequencing
Optimizing mycobacterial phenotypic drug susceptibility testing
Watch highlights from the Virtual Microbiology & Infectious Disease Summit 2022
Catch up on talks led by world-class clinicians and scientists on the latest research, top techniques, and innovative technology
Roche receives FDA authorization for semi-quantitative test to measure the level of SARS-CoV-2 antibodies
Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS- CoV-2 spike protein
Indica Labs and Lunit form strategic alliance for digital pathology AI workflows
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
Independent market research says 84% of US Healthcare professionals likely to use Orviglance in target population
Research confirms the unmet need for an effective alternative to unenhanced MRI and a safe alternative to GBCAs
Bosch and Randox invest in the Vivalytic analysis platform
Smartphone-sized laboratory – Sepsis IVD grade test based on cutting-edge BioMEMS technology is a joint development objective
Quantitative microscopy for precision spatial biology: “From samples to knowledge”
In this guest editorial by Dr. Zbigniew Mikulski from the La Jolla Institute for Immunology, explore the fascinating advancements in microscopy and their role in facilitating the generation of high-resolution quantitative data, suited for translational and clinical spatial analysis